SCHEMBL16709336

SCHEMBL16709336

CCOC(=O)/C(C)=C\c1cc(OC)ccc1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 2/20 0.46
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 4/20 0.42
HPGD P15428 4/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 6/20 0.42
LMNA P02545 5/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
PLIN1 O60240 1/20 0.42
POLB P06746 1/20 0.42
PLIN5 Q00G26 1/20 0.42
ABHD5 Q8WTS1 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
S1PR4 O95977 1/20 0.41
S1PR1 P21453 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL825027 0.89 LMNA (0.55) FBP1HDAC3HDAC1HDAC2KDM4E
SCHEMBL9358863 0.86 ERN1 (0.53) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL9363017 0.83 MIF (0.53) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL9358717 0.83 MIF (0.53) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL7526723 0.83 MAPT (0.51) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL16906141 0.82 ALDH1A1 (0.43) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL28979275 0.82 ALDH1A1 (0.47) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL28461706 0.80 HDAC3 (0.40) FBP1HDAC3HDAC1HDAC2KDM4E
SCHEMBL20714324 0.79 ALDH1A1 (0.47) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL30467450 0.79 ALDH1A1 (0.47) KDM4EALDH1A1HPGDGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556204-B2 Methods and intermediates for the preparation of (4bS,5aR)-12-cyclohexyl-N-(N,N-dimethylsulfamoyl)-3-methoxy-5a-((1R,5S)-3-methyl-3,8-diazabicyclo [3.2.1]octane-8-carbonyl)-4b,5,5a,6-tetrahydrobenzo [3,4]cyclopropa[5,6]azepino[1,2-A]indole-9-carboxamide BRISTOL-MYERS SQUIBB COMPANY (US) 2017-01-31 US disclosed
US-20150133654-A1 NOVEL METHODS AND INTERMEDIATES FOR THE PREPARATION OF (4bS,5aR)-12-CYCLOHEXYL-N-(N,N-DIMETHYLSULFAMOYL)-3-METHOXY-5a-((1R,5S)-3-METHYL-3,8-DIAZABICYCLO[3.2.1]OCTANE-8-CARBONYL)-4b,5,5a,6-TETRAHYDROBENZO [3,4]CYCLOPROPA[5,6]AZEPINO[1,2-A]INDOLE-9-CARBOXAMIDE BRISTOL-MYERS SQUIBB COMPANY 2015-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150133654-A1 NOVEL METHODS AND INTERMEDIATES FOR THE PREPARATION OF (4bS,5aR)-12-CYCLOHEXYL-N-(N,N-DIMETHYLSULFAMOYL)-3-METHOXY-5a-((1R,5S)-3-METHYL-3,8-DIAZABICYCLO[3.2.1]OCTANE-8-CARBONYL)-4b,5,5a,6-TETRAHYDROBENZO [3,4]CYCLOPROPA[5,6]AZEPINO[1,2-A]INDOLE-9-CARBOXAMIDE HTR3C, HTR2C, HTR1B FBP1 2422/4885HDAC3 299/4885HDAC1 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.